(Q45128179)

9 December 2017

Clinical efficacy of Apomorphine SL in erectile dysfunction of diabetic men. (English)

1 reference

9 December 2017

1 reference

1 reference

1

1 reference

9 December 2017

8

1 reference

9 December 2017

D'Antonio R

2

1 reference

9 December 2017

Pretti G

3

1 reference

9 December 2017

Fontana F

4

1 reference

9 December 2017

Panella M

5

1 reference

9 December 2017

Kocjancic E

6

1 reference

9 December 2017

Allochis G

7

1 reference

9 December 2017

1 January 2005

1 reference

International Journal of Impotence Research

9 December 2017

1 reference

9 December 2017

17

1 reference

9 December 2017

1

1 reference

9 December 2017

80-85

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ijir.3901273

9 December 2017

0 references

cites work

Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901273

Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901273

Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901273

Radicals and oxidative stress in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901273

Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901273

Efficacy of oral sildenafil in the treatment of erectile dysfunction in diabetic men with positive response to intracavernosal injection of alprostadil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901273

A therapeutic taxonomy of treatments for erectile dysfunction: an evolutionary imperative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901273

Double-blind, crossover comparison of 3 mg apomorphine SL with placebo and with 4 mg apomorphine SL in male erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901273

An open-label, uncontrolled dose-optimization study of sublingual apomorphine in erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901273

Management of sexual dysfunction in patients with cardiovascular disease: recommendations of The Princeton Consensus Panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901273

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901273

Is there an optimal time for intracavernous prostaglandin E1 rehabilitation following nonnerve sparing radical prostatectomy? Results from a hemodynamic prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901273

Apomorphine: an update of clinical trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901273

Sequential administration enhances the effect of apomorphine SL in men with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901273

Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901273

Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901273

Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901273

Value of color Doppler sonography in the diagnosis of venous impotence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901273

inferred from DOI database lookup

7 January 2021

based on heuristic

Intracavernous injection of papaverine as a diagnostic and therapeutic method in erectile failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901273

inferred from DOI database lookup

7 January 2021

based on heuristic

Nomogram for Penile Biothesiometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901273

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.IJIR.3901273

1 reference

Dimensions Publication ID

9 December 2017

0 references

1 reference